Evidence map›Paper›PMID 41892290›Full record

ReviewCells2026

The Role of Glycolysis in Tumorigenesis-The Many Unresolved Issues.

Fabrizio Marcucci, Shibo Wei, Marco Cordani

Abstract readReview
In one paragraph

Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fabrizio MarcucciDepartment of Pharmacological and Biomolecular Sciences, University of Milan, via Trentacoste 2, 20134 Milan, Italy.ORCID 0000-0002-2977-294X
Shibo WeiDepartment of Precision Medicine, School of Medicine, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.ORCID 0000-0001-9283-9804
Marco CordaniDepartment of Biochemistry and Molecular Biology, Faculty of Biological Sciences, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0001-9342-4862

Funding

MICIU/AEI/10.13039/501100011033 RYC2021-031003I
6 · The paper itself

Abstract

The upregulation of glycolysis and resultant lactate production (hereafter referred to as fermentative glycolysis) even under normoxic conditions has been considered a hallmark of cancer. In recent years, however, it has become clear that fermentative glycolysis in tumors is not as all-inclusive as originally thought. Nevertheless, many tumor types at different stages of progression are characterized by a predominantly glycolytic metabolism. Fermentative glycolysis in tumors supports several different functions: energy production in the form of adenosine triphosphate molecules, the maintenance and amplification of glycolytic metabolism itself, the feeding of oxidative metabolism through the production of lactate, the generation of metabolic intermediates for biomass production, and the execution of non-metabolic, non-canonical, so-called moonlighting functions. This knowledge, however, raises a number of different questions which, by and large, are still unanswered today. Are there different degrees of glycolysis upregulation in order to support the different functions? How is fermentative glycolysis maintained even under normoxic conditions? Why do moonlighting functions exist, given that they are unrelated to the metabolic steps of glycolysis? Moonlighting functions are generally discussed in the context of tumorigenesis, but do they exist also in non-transformed cells? Do they occur in a coordinated manner in all tumor cells or are they activated selectively depending on the tumor type, tumor stage, or on the inducing stimulus? While these issues are mostly unresolved, in this article we propose some tentative answers which, we hope, may promote new research directions which may further our understanding in this field.

Indexed as

CarcinogenesisGlycolysisNeoplasmsAnimalsHumansLactic AcidMetabolic ReprogrammingLactic Aciddangerglycolysislactatemoonlightingstresstumorigenesis

Identifiers

PMID41892290
PMCPMC13025559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.